Back

Immediate and mid-term effect of a natural topical product in patients with musculoskeletal pain: randomized, double-blinded, and placebo-controlled clinical trial.

UNZURRUNZAGA, R.; Unzueta, I.; Nishishinya, B.; Lucenteforte, G.; Barastegui, D.; Arcalis, A.; Cugat, R.; Ramon, S.

2021-11-05 pain medicine
10.1101/2021.11.04.21265860
Show abstract

IntroductionMusculoskeletal pain is a common affection due to ageing, sedentarism and injuries. The objective of this trial is to prove efficacy of a natural topical composition containing Arnica montana, Hypericum perforatum, Calendula officinalis, Melaleuca sp. and menthol in pain management in adults with acute or chronic pain. MethodsThis randomized, double-blinded and placebo-controlled trial included 200 patients with musculoskeletal pain, 100 in the intervention group receiving the topical formula and 100 in the placebo group, receiving a similar formula without active ingredients. The products were applied topically twice daily for 14 days in affected areas. Immediate pain alleviation and stiffness perception were monitored for two hours at days 0, 7 at 14. Pain reduction and recovery perception upon sustained application were assessed after 7 and 14 days. ResultsIntervention immediately reduced pain and stiffness at rest and in motion 30 minutes after application and kept being superior to placebo in all short-term timepoints (p < 0.05). Immediate pain reduction was maintained even at late stages of recovery. A two-week sustained intervention resulted in significant pain reduction and improvement in recovery perception. Even if both groups reached statistical significance with respect to baseline due to spontaneous lesion recovery, a significantly improved recovery was reported in the intervention group with respect to placebo. ConclusionsIntervention was found to reduce pain and stiffness upon minutes of its application and to improve pain and mobility over the 14 days of treatment, showing benefits both for immediate alleviation and for longer term recovery. Level of EvidenceTherapeutic Level I

Matching journals

1
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 17%
1.7× avg
2
Pain
Ovid Technologies (Wolters Kluwer Health) · based on 15 published papers
Top 0.3%
90× avg
3
BMC Neurology
Springer Science and Business Media LLC · based on 11 published papers
#1
98× avg
4
The Journal of Pain
Elsevier BV · based on 11 published papers
Top 0.3%
105× avg
5
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 26%
6.9%
6
Frontiers in Human Neuroscience
Frontiers Media SA · based on 11 published papers
Top 0.2%
82× avg
7
BMJ Open
BMJ · based on 553 published papers
Top 19%
1.5× avg
8
Frontiers in Digital Health
Frontiers Media SA · based on 18 published papers
Top 0.5%
22× avg
9
Clinical Pharmacology & Therapeutics
Wiley · based on 19 published papers
Top 0.7%
22× avg
10
Clinical and Translational Science
Wiley · based on 14 published papers
Top 0.5%
28× avg
11
BJGP Open
Royal College of General Practitioners · based on 12 published papers
Top 0.9%
22× avg
12
Cureus
Springer Science and Business Media LLC · based on 64 published papers
Top 10%
2.5× avg
13
BMJ Open Quality
BMJ · based on 15 published papers
Top 1%
16× avg
14
Medicine
Ovid Technologies (Wolters Kluwer Health) · based on 29 published papers
Top 5%
4.5× avg
15
Frontiers in Neuroscience
Frontiers Media SA · based on 29 published papers
Top 2%
9.0× avg
16
Social Science & Medicine
Elsevier BV · based on 15 published papers
Top 1%
16× avg
17
Neuroscience & Biobehavioral Reviews
Elsevier BV · based on 19 published papers
Top 2%
11× avg
18
Journal of Medical Internet Research
JMIR Publications Inc. · based on 81 published papers
Top 11%
1.9× avg
19
PLOS Neglected Tropical Diseases
Public Library of Science (PLoS) · based on 166 published papers
Top 9%
1.3%
20
Frontiers in Immunology
Frontiers Media SA · based on 140 published papers
Top 6%
2.6× avg
21
Blood Advances
American Society of Hematology · based on 16 published papers
Top 1%
11× avg
22
British Journal of Anaesthesia
Elsevier BV · based on 13 published papers
Top 2%
6.1× avg
23
Brain Sciences
MDPI AG · based on 19 published papers
Top 2%
9.3× avg